Side Effects of Adjuvant Treatment of Breast Cancer
Top Cited Papers
- 28 June 2001
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 344 (26), 1997-2008
- https://doi.org/10.1056/nejm200106283442607
Abstract
Women with primary invasive breast cancer receive both local and systemic treatment. Surgery and radiation therapy are local treatments given to reduce the risk of recurrent cancer in the breast, chest wall, and regional lymph nodes. In some cases, these local treatments may prevent the dissemination of cancer and may reduce mortality from breast cancer. Cytotoxic chemotherapy and hormonal therapy are systemic treatments given after local treatment to reduce systemic recurrences and overall mortality from breast cancer. Recent guidelines from the National Institutes of Health Consensus Conference, the National Comprehensive Cancer Center Network, and other groups recommend adjuvant chemotherapy, tamoxifen, . . .Keywords
This publication has 107 references indexed in Scilit:
- Acute Myeloid LeukemiaNew England Journal of Medicine, 1999
- Polychemotherapy for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal WomenNew England Journal of Medicine, 1997
- Femoral fractures in postmenopausal breast cancer patients treated with adjuvant tamoxifenBreast Cancer Research and Treatment, 1996
- Sequential or alternating doxorubicin and CMF regimens in breast cancer with more than three positive nodes. Ten-year resultsPublished by American Medical Association (AMA) ,1995
- Estrogen replacement therapy in breast cancer survivors. A time for change. Breast Cancer Committees of the Eastern Cooperative Oncology GroupPublished by American Medical Association (AMA) ,1994
- Risk of Leukemia after Chemotherapy and Radiation Treatment for Breast CancerNew England Journal of Medicine, 1992
- Adjuvant chemotherapy in early breast cancer and incidence of new primary malignanciesThe Lancet, 1991
- A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive TumorsNew England Journal of Medicine, 1989
- Postoperative adjuvant chemotherapy with fluorouracil, doxorubicin, cyclophosphamide, and BCG vaccine. A follow-up reportJAMA, 1979